A clinical trial study on PEGylated-asparaginase-encapsulated in erythrocytes for patients with acute lymphoblastic leukemia (ALL) is also underway [NCT03267030] [117] as shown in Table 3. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.